Anika Therapeutics (ANIK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 89,042 | 133,256 | 104,261 | 110,707 | 100,156 |
| Marketable Securities | 69,972 | 24,000 | 20,500 | 27,751 | 6,750 |
| Receivables | 20,775 | 23,825 | 27,598 | 21,652 | 17,152 |
| Inventories | 21,300 | 22,035 | 15,983 | 14,938 | 12,407 |
| TOTAL | $202,943 | $206,327 | $170,440 | $176,433 | $137,836 |
| Non-Current Assets | |||||
| PPE Net | 54,111 | 56,183 | 52,296 | 40,108 | 31,669 |
| Intangibles | 17,042 | 18,853 | 17,441 | 19,138 | 23,234 |
| Other Non-Current Assets | 4,897 | 1,254 | 69 | 69 | 69 |
| TOTAL | $76,050 | $76,290 | $69,806 | $59,315 | $54,972 |
| Total Assets | $278,993 | $282,617 | $240,246 | $235,748 | $192,808 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,143 | 6,747 | 2,303 | 8,302 | 1,201 |
| Accrued Expenses | 8,146 | 6,326 | 6,496 | 4,778 | 4,772 |
| TOTAL | $11,289 | $13,073 | $8,799 | $17,278 | $5,973 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | N/A | 102 |
| Other Non-Current Liabilities | 550 | 660 | 2,126 | 781 | 894 |
| TOTAL | $4,092 | $6,053 | $8,674 | $7,622 | $8,737 |
| Total Liabilities | $15,381 | $19,126 | $17,473 | $24,900 | $14,710 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 14,212 | 14,694 | 14,639 | 14,330 | 14,546 |
| Common Shares | 142 | 147 | 146 | 150 | 149 |
| Retained earnings | 218,233 | 199,511 | 168,209 | 135,662 | 104,904 |
| Other shareholders' equity | -5,526 | -4,784 | -7,317 | -6,649 | -4,495 |
| TOTAL | $263,612 | $263,491 | $222,773 | $210,848 | $178,098 |
| Total Liabilities And Equity | $278,993 | $282,617 | $240,246 | $235,748 | $192,808 |